Newsbreak

Second Judiciary Committee hearing on Planned Parenthood set for Thurs, Oct. 8

The House Judiciary Committee has announced that its second hearing into Planned Parenthood’s fetal organ trafficking activities will take place on Thursday, October 8.

Following last week’s Congressional hearing, during which members questioned Planned Parenthood CEO Cecile Richards, this week’s will focus on the details of abortion procedures, particularly late-term abortions, and medical analysis of the ramifications of altering abortion techniques to acquire intact, usable organs.

Anthony-Levatino

Dr. Anthony Levatino

Witnesses include Dr. Anthony Levatino (pictured right), a former abortionist who now works to raise awareness of the practice’s barbarity, former Planned Parenthood manager Sue Thayer, American Constitution Society president Caroline Fredrickson, and Luana Stoltenberg, a post-abortive woman turned pro-life speaker.

“Thursday’s hearing will be another opportunity for members of the House Judiciary Committee and the American public to understand the horrific details involved in late-term abortions and what is required in order to harvest baby body parts,” Committee Chair Bob Goodlatte (R-VA) and Constitution and Civil Justice Subcommittee Chair Trent Franks (R-AZ) said. “The Committee will assemble a panel of medical experts and witnesses who have firsthand knowledge of the atrocities that occur within an abortion clinic.”

What is Live Action News?

Live Action News is pro-life news and commentary from a pro-life perspective. Learn More

Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.

GUEST ARTICLES: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated. (See here for Open License Agreement.) Thank you for your interest in Live Action News!



To Top